MAX BioPharma Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $13M

  • Investors
  • 7

MAX BioPharma General Information

Description

Developer of novel small-molecule lipids designed to provide treatments for fatal and debilitating disorders. The company develops oxysterols that can stimulate bone growth and block cancer cell growth as well as inhibit their ability to metastasize, enabling doctors to treat pancreatic cancer, breast cancer, and hematologic malignancies.

Contact Information

Website
www.maxbiopharma.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2870 Colorado Avenue
  • Santa Monica, CA 90404
  • United States
+1 (310)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 2870 Colorado Avenue
  • Santa Monica, CA 90404
  • United States
+1 (310)

MAX BioPharma Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MAX BioPharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC (Series A) 06-Aug-2025 $13M Completed Pre-Clinical Trials
10. Grant 01-May-2023 Completed Pre-Clinical Trials
9. Grant 23-May-2022 Completed Pre-Clinical Trials
8. Grant 01-Sep-2021 Completed Pre-Clinical Trials
7. Later Stage VC (Series A) 02-Feb-2021 Cancelled Pre-Clinical Trials
6. Grant 27-Aug-2020 Completed Pre-Clinical Trials
5. Later Stage VC (Series A) 03-Mar-2020 Cancelled Pre-Clinical Trials
4. Equity Crowdfunding 13-Sep-2018 Completed Pre-Clinical Trials
3. Accelerator/Incubator 01-Jan-2018 $250K Completed Startup
2. Seed Round $250K $250K Completed Startup
To view MAX BioPharma’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

MAX BioPharma Patents

  • 20

    Total Documents Applications and Grants

  • Total Patents Families

  • 9

    Granted

  • 5

    Pending

  • Expiring in next 12 mo

MAX BioPharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021376205-A1 Methods and compositions for treating fibrotic diseases Pending 05-Nov-2020
CA-3197810-A1 Methods and compositions for treating fibrotic diseases Pending 05-Nov-2020
EP-4240368-A1 Methods and compositions for treating fibrotic diseases Pending 05-Nov-2020
EP-4240368-A4 Methods and compositions for treating fibrotic diseases Pending 05-Nov-2020
US-20230381201-A1 Methods and compositions for treating fibrotic diseases Pending 05-Nov-2020 A61K31/58
To view MAX BioPharma’s complete patent history, request access »

MAX BioPharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MAX BioPharma Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Technomark Life Sciences Venture Capital Minority
National Institutes of Health Government
California Institute for Regenerative Medicine Government
National Institute on Aging Government
National Institutes of Arthritis and Musculoskeletal Diseases Not-For-Profit Venture Capital
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

MAX BioPharma FAQs

  • When was MAX BioPharma founded?

    MAX BioPharma was founded in 2010.

  • Where is MAX BioPharma headquartered?

    MAX BioPharma is headquartered in Santa Monica, CA.

  • What is the size of MAX BioPharma?

    MAX BioPharma has 5 total employees.

  • What industry is MAX BioPharma in?

    MAX BioPharma’s primary industry is Drug Discovery.

  • Is MAX BioPharma a private or public company?

    MAX BioPharma is a Private company.

  • What is MAX BioPharma’s current revenue?

    The current revenue for MAX BioPharma is .

  • How much funding has MAX BioPharma raised over time?

    MAX BioPharma has raised $13.3M.

  • Who are MAX BioPharma’s investors?

    Technomark Life Sciences, National Institutes of Health, California Institute for Regenerative Medicine, National Institute on Aging, and National Institutes of Arthritis and Musculoskeletal Diseases are 5 of 7 investors who have invested in MAX BioPharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process